Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1981-1990 of 2876 for cancer

Edit search filters
  1. Long Term Outcomes In Pancreas Cancer Patients

    Rochester, MN

  2. Cancer-Related Fatigue Amongst Cutaneous Oncology Patients

    Rochester, MN

  3. Management of Locoregional Recurrent Breast Cancer

    Rochester, MN

  4. Resectable, Borderline Resectable, And Locally Advanced Pancreatic Cancer Biorepository Of Peripheral Blood

    Rochester, MN

  5. Leveraging Methylated DNA Markers (MDMs) In The Detection Of Endometrial Cancer And Cervical Cancer: A Phase II Clinical Study

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Rochester, MN

  6. Tumor Infiltrating Lymphocytes Biobank

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Hepatobiliary Cancer Research Engagement Among Patients And Communities

    Jacksonville, FL

  8. HTN Management And Cardiovascular Adverse Event Prevention In B-Cell Malignancies Undergoing BTKi

    Rochester, MN

  9. Broad Evidence Of Systemic Immune Activation In Long Term Survivors Of Advanced Ovarian Cancer

    Jacksonville, FL, Rochester, MN

  10. Gut Microbiome In Solid Tumor Management

    Rochester, MN

.

Mayo Clinic Footer